C-reactive protein levels in relation to various features of non-alcoholic fatty liver disease among obese patients

Journal of Hepatology

Volumn 55, Issue 3, 2011, Pages 660-665

  Zimmermann, Esther ^a,b   Anty, Rodolphe ^c,d,e   Tordjman, Joan ^c,f,g,h,i   Verrijken, An ^j   Gual, Philippe ^c,d,e   Tran, Albert ^c,d,e   Iannelli, Antonio ^c,d,e   Gugenheim, Jean ^c,d,e   Bedossa, Pierre ^k,l   Francque, Sven ^j   Le Marchand Brustel, Yannick ^c,d,e   Clement, Karine ^c,f,g,h,i   Van Gaal, Luc ^j   Sørensen, Thorkild I A ^a   Jess, Tine ^a  

^a The Capital Region   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c INSERM   (France)

^d UNIVERSITY HOSPITAL OF NICE   (France)

^e UNIVERSITÉ CÔTE D'AZUR   (France)

^f CENTRE DE RECHERCHE DES CORDELIERS   (France)

^g UNIVERSITÉ PARIS DESCARTES   (France)

^h PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

ⁱ CENTRE MAURICE HALBWACHS   (France)

^j ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^k BEAUJON HOSPITAL   (France)

^l CENTRE DE RECHERCHE BIOMÉDICALE BICHAT BEAUJON CRB3   (France)

more..

Author keywords

Body mass index; C reactive protein; Non alcoholic fatty liver disease

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; BELGIUM; BODY MASS; CLINICAL FEATURE; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; FATTY LIVER; FEMALE; FRANCE; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER CELL; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADIPOSITY; ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; FATTY LIVER; FEMALE; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; OBESITY; SEVERITY OF ILLNESS INDEX; YOUNG ADULT;

EID: 84860390493     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2010.12.017     Document Type: Article

References (29)

1. D.E. Kleiner, E.M. Brunt, N.M. Van, C. Behling, M.J. Contos, and O.W. Cummings Design and validation of a histological scoring system for nonalcoholic fatty liver disease Hepatology 41 2005 1313 1321 (Pubitemid 40770284)
2. H. Boppidi, and S.R. Daram Nonalcoholic fatty liver disease: hepatic manifestation of obesity and the metabolic syndrome Postgrad Med 120 2008 E01 E07
3. D.B. Panagiotakos, C. Pitsavos, M. Yannakoulia, C. Chrysohoou, and C. Stefanadis The implication of obesity and central fat on markers of chronic inflammation: The ATTICA study Atherosclerosis 183 2005 308 315 (Pubitemid 41579282)
4. N. Pannacciulli, F.P. Cantatore, A. Minenna, M. Bellacicco, R. Giorgino, and P.G. De C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women Int J Obes Relat Metab Disord 25 2001 1416 1420 (Pubitemid 32977856)
5. H.S. Park, J.Y. Park, and R. Yu Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6 Diabetes Res Clin Pract 69 2005 29 35 (Pubitemid 40813409)
6. K.M. Rexrode, A. Pradhan, J.E. Manson, J.E. Buring, and P.M. Ridker Relationship of total and abdominal adiposity with CRP and IL-6 in women Ann Epidemiol 13 10 2003 674 682 (Pubitemid 37346407)
7. J. Warnberg, E. Nova, L.A. Moreno, J. Romeo, M.I. Mesana, and J.R. Ruiz Inflammatory proteins are related to total and abdominal adiposity in a healthy adolescent population: the AVENA Study Am J Clin Nutr 84 2006 505512
8. R. Anty, S. Bekri, N. Luciani, M.C. Saint-Paul, M. Dahman, and A. Iannelli The inflammatory C-reactive protein is increased in both liver and adipose tissue in severely obese patients independently from metabolic syndrome, type 2 diabetes, and NASH Am J Gastroenterol 101 2006 1824 1833 (Pubitemid 44166593)
9. N.J. Timpson, D.A. Lawlor, R.M. Harbord, T.R. Gaunt, I.N. Day, and L.J. Palmer C-reactive protein and its role in metabolic syndrome: Mendelian randomisation study Lancet 366 2005 1954 1959 (Pubitemid 41713985)
10. T.A. Pearson, G.A. Mensah, R.W. Alexander, J.L. Anderson, and R.O. Cannon III Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association Circulation 107 2003 499 511 (Pubitemid 36158056)
11. P.M. Ridker, C.H. Hennekens, J.E. Buring, and N. Rifai C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843 (Pubitemid 30165206)
12. M. Koruk, S. Taysi, M.C. Savas, O. Yilmaz, F. Akcay, and M. Karakok Serum levels of acute phase proteins in patients with nonalcoholic steatohepatitis Turk J Gastroenterol 14 2003 12 17 (Pubitemid 36569840)
13. S.H. Park, B.I. Kim, J.W. Yun, J.W. Kim, D.I. Park, and Y.K. Cho Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men J Gastroenterol Hepatol 19 2004 694698
14. G. Targher, L. Bertolini, L. Scala, G. Zoppini, L. Zenari, and G. Falezza Non-alcoholic hepatic steatosis and its relation to increased plasma biomarkers of inflammation and endothelial dysfunction in non-diabetic men. Role of visceral adipose tissue Diabet Med 22 2005 1354 1358 (Pubitemid 41391311)
15. G. Targher Relationship between high-sensitivity C-reactive protein levels and liver histology in subjects with non-alcoholic fatty liver disease J Hepatol 45 2006 879 881 (Pubitemid 44646692)
16. M. Yoneda, H. Mawatari, K. Fujita, H. Iida, K. Yonemitsu, and S. Kato High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH J Gastroenterol 42 2007 573 582 (Pubitemid 47190075)
17. J.W. Haukeland, J.K. Damas, Z. Konopski, E.M. Loberg, T. Haaland, and I. Goverud Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2 J Hepatol 44 2006 1167 1174
18. J.M. Hui, G.C. Farrell, J.G. Kench, and J. George High sensitivity C-reactive protein values do not reliably predict the severity of histological changes in NAFLD Hepatology 39 2004 1458 1459 (Pubitemid 38569072)
19. A. Kotronen, and H. Yki-Jarvinen Fatty liver: a novel component of the metabolic syndrome Arterioscler Thromb Vasc Biol 28 2008 27 38
20. J. Tordjman, C. Poitou, D. Hugol, J.L. Bouillot, A. Basdevant, and P. Bedossa Association between omental adipose tissue macrophages and liver histopathology in morbid obesity: influence of glycemic status J Hepatol 51 2009 354 362
21. S. Francque, A. Verrijken, I. Mertens, G. Hubens, M.E. Van, and P. Pelckmans Visceral adiposity and insulin resistance are independent predictors of the presence of non-cirrhotic NAFLD-related portal hypertension Int J Obes (Lond) 5 2010 6 7
22. E.A. Bermudez, N. Rifai, J.E. Buring, J.E. Manson, and P.M. Ridker Relation between markers of systemic vascular inflammation and smoking in women Am J Cardiol 89 2002 1117 1119 (Pubitemid 34462860)
23. M.H. Wener, P.R. Daum, and G.M. McQuillan The influence of age, sex, and race on the upper reference limit of serum C-reactive protein concentration J Rheumatol 27 2000 2351 2359
24. S.G. Lakoski, M. Cushman, M. Criqui, T. Rundek, R.S. Blumenthal, and R.B. D'Agostino Jr. Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort Am Heart J 152 2006 593 598 (Pubitemid 44233418)
25. U. Ariz, J.M. Mato, S.C. Lu, and M.L. Martinez Chantar Nonalcoholic steatohepatitis, animal models, and biomarkers: what is new? Methods Mol Biol 593 2010 109136
26. M. Fasshauer, and R. Paschke Regulation of adipocytokines and insulin resistance Diabetologia 46 2003 1594 1603 (Pubitemid 38005321)
27. V. Mohamed-Ali, S. Goodrick, A. Rawesh, D.R. Katz, J.M. Miles, and J.S. Yudkin Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo J Clin Endocrinol Metab 82 1997 4196 4200 (Pubitemid 27525539)
28. N. Ouchi, S. Kihara, T. Funahashi, T. Nakamura, M. Nishida, and M. Kumada Reciprocal association of C-reactive protein with adiponectin in blood stream and adipose tissue Circulation 107 2003 671 674 (Pubitemid 36222590)
29. R. Bataille, and B. Klein C-reactive protein levels as a direct indicator of interleukin-6 levels in humans in vivo Arthritis Rheum 35 1992 982 984